3 Promising Penny Stocks With Over $400M Market Cap

Simply Wall St.02-09 19:05

As February begins, the U.S. stock market has shown a robust start with major indexes like the Dow Jones and S&P 500 posting significant gains. For investors interested in exploring beyond well-known ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2610589586?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/3242000-choice1-main-header/1585186612362","is_english":true,"pubTime":"2026-02-09 19:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2610589586","market":"us","top_or_hot":-1,"title":"3 Promising Penny Stocks With Over $400M Market Cap","media":"Simply Wall St.","content":"<div>\n<p>As February begins, the U.S. stock market has shown a robust start with major indexes like the Dow Jones and S&P 500 posting significant gains. For investors interested in exploring beyond well-known ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/transportation/otc-didi.y/didi-global/news/3-promising-penny-stocks-with-over-400m-market-cap\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Promising Penny Stocks With Over $400M Market Cap</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Promising Penny Stocks With Over $400M Market Cap\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-09 19:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/transportation/otc-didi.y/didi-global/news/3-promising-penny-stocks-with-over-400m-market-cap><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As February begins, the U.S. stock market has shown a robust start with major indexes like the Dow Jones and S&P 500 posting significant gains. For investors interested in exploring beyond well-known ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/transportation/otc-didi.y/didi-global/news/3-promising-penny-stocks-with-over-400m-market-cap\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4180","symbol_name":"家用器具与特殊消费品","start_time":0,"source_url":"https://simplywall.st/stocks/us/transportation/otc-didi.y/didi-global/news/3-promising-penny-stocks-with-over-400m-market-cap","article_id":"2610589586","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/3242000-choice1-main-header/1585186612362"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/transportation/otc-didi.y/didi-global/news/3-promising-penny-stocks-with-over-400m-market-cap","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2610589586","pubTimestamp":1770635113,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"As February begins, the U.S. stock market has shown a robust start with major indexes like the Dow Jones and S&P 500 posting significant gains. For investors interested in exploring beyond well-known stocks, penny stocks—often associated with smaller or newer companies—continue to hold appeal despite their somewhat outdated label. These stocks can offer a blend of affordability and growth potential, especially when backed by solid financial foundations, making them intriguing options for...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4180":"家用器具与特殊消费品","BK4007":"制药","BK4134":"信息科技咨询与其它服务","ELTP":"Elite Pharmaceuticals, Inc.","BK4551":"寇图资本持仓","BK4509":"腾讯概念","BK4539":"次新股","LU0049112450.USD":"FIDELITY PACIFIC \"A\" INC","BK4023":"应用软件","LCUT":"生活时光品牌家具","WDH":"水滴","BK4161":"工业机械","BK4113":"食品零售","CRCT":"Cricut, Inc.","MAPS":"WM Technology, Inc.","BK4531":"中概回港概念","NEPH":"Nephros, Inc.","LU1235295612.USD":"FIDELITY PACIFIC \"A\" (USDHDG) INC","LX":"乐信","GDRX":"GoodRx Holdings, Inc.","BK4173":"保险经纪商","BABB":"BAB, Inc.","LU1046422090.SGD":"Fidelity Pacific A-SGD","BK4167":"医疗保健技术","DDL":"叮咚买菜","BK4209":"餐馆","BK4166":"消费信贷","BK4191":"家用电器","BK4579":"人工智能","CINT":"CI&T Inc."},"translate_title":"3只市值超过4亿美元的有前途的细价股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MAPS":1,"CRCT":1,"GDRX":1,"LCUT":1,"WDH":1,"NEPH":1,"BABB":1,"ELTP":1,"CINT":1,"LX":1,"DDL":1},"content_text":"As February begins, the U.S. stock market has shown a robust start with major indexes like the Dow Jones and S&P 500 posting significant gains. For investors interested in exploring beyond well-known stocks, penny stocks—often associated with smaller or newer companies—continue to hold appeal despite their somewhat outdated label. These stocks can offer a blend of affordability and growth potential, especially when backed by solid financial foundations, making them intriguing options for those seeking diverse investment opportunities.AdvertisementTop 10 Penny Stocks In The United StatesNameShare PriceMarket CapRewards & RisksDingdong (Cayman) (DDL)$2.74$587.2M✅ 4 ⚠️ 1 View Analysis >Waterdrop (WDH)$1.85$669.08M✅ 4 ⚠️ 0 View Analysis >WM Technology (MAPS)$0.7151$122.3M✅ 4 ⚠️ 1 View Analysis >LexinFintech Holdings (LX)$2.81$472.82M✅ 4 ⚠️ 1 View Analysis >CI&T (CINT)$4.97$645.19M✅ 5 ⚠️ 0 View Analysis >Golden Growers Cooperative (GGRO.U)$5.00$77.45M✅ 2 ⚠️ 5 View Analysis >Cricut (CRCT)$4.62$978.26M✅ 2 ⚠️ 2 View Analysis >Nephros (NEPH)$3.87$41.13M✅ 3 ⚠️ 2 View Analysis >BAB (BABB)$0.9605$6.98M✅ 2 ⚠️ 3 View Analysis >Lifetime Brands (LCUT)$3.34$75.67M✅ 3 ⚠️ 2 View Analysis >Click here to see the full list of 341 stocks from our  US Penny Stocks screener.Underneath we present a selection of stocks filtered out by our screen.GoodRx Holdings (GDRX)Simply Wall St Financial Health Rating: ★★★★★★Overview: GoodRx Holdings, Inc. provides consumers with tools to compare prices and save on prescription drugs in the United States, with a market cap of approximately $828.22 million.Operations: The company's revenue primarily comes from its Healthcare Software segment, which generated approximately $800.65 million.Market Cap: $828.22MGoodRx Holdings, with a market cap of US$828.22 million, has shown financial stability and growth potential as a penny stock. The company became profitable recently and maintains a satisfactory net debt to equity ratio of 35.9%. Its short-term assets exceed both short- and long-term liabilities, indicating solid financial health. Recent strategic alliances, such as with Surescripts for Script Corner and partnerships for medication savings like ARAKODA®, enhance its market position by offering consumers significant prescription cost reductions. These initiatives could strengthen GoodRx's role in the healthcare software segment while supporting pharmacy partners through innovative affordability solutions.Get an in-depth perspective on GoodRx Holdings' performance by reading our balance sheet health report here.Learn about GoodRx Holdings' future growth trajectory here.GDRX Debt to Equity History and Analysis as at Feb 2026DiDi Global (DIDI.Y)Simply Wall St Financial Health Rating: ★★★★★☆Overview: DiDi Global Inc. operates a mobility technology platform offering various mobility and related services across China, Brazil, Mexico, and other international markets, with a market cap of approximately $22.89 billion.Operations: The company generates revenue from three main segments: China Mobility (CN¥197.60 billion), International (CN¥13.53 billion), and Other Initiatives (CN¥10.04 billion).Market Cap: $22.89BDiDi Global, with a market cap of approximately $22.89 billion, operates across multiple international markets and has shown signs of financial resilience despite being unprofitable. The company reported third-quarter sales of CN¥58.59 billion, an increase from the previous year, alongside a net income rise to CN¥1.46 billion. DiDi's management and board are experienced, contributing to strategic decisions like share buybacks totaling $286.1 million recently completed. While trading below estimated fair value and maintaining more cash than debt, DiDi's positive free cash flow supports a stable cash runway exceeding three years despite increased debt levels over time.Navigate through the intricacies of DiDi Global with our comprehensive balance sheet health report here.Review our growth performance report to gain insights into DiDi Global's future.DIDI.Y Financial Position Analysis as at Feb 2026Elite Pharmaceuticals (ELTP)Simply Wall St Financial Health Rating: ★★★★★★Overview: Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing, manufacturing, and selling oral controlled-release and generic pharmaceuticals with a market cap of $481.05 million.Operations: The company's revenue primarily comes from its Abbreviated New Drug Applications (ANDA) segment, generating $122.89 million.Market Cap: $481.05MElite Pharmaceuticals has demonstrated financial improvement, reporting a significant increase in revenue to US$36.32 million for the recent quarter, up from US$18.88 million the previous year. The company transitioned from a net loss to a net income of US$13.7 million, highlighting its profitability shift over the past year. Elite's strong financial position is further supported by its substantial cash reserves exceeding total debt and robust operating cash flow coverage of debt at 739%. With experienced management and board members, Elite remains undervalued by approximately 90% compared to fair value estimates, offering potential investment appeal amidst stable volatility levels.Take a closer look at Elite Pharmaceuticals' potential here in our financial health report.Examine Elite Pharmaceuticals' past performance report to understand how it has performed in prior years.ELTP Financial Position Analysis as at Feb 2026Turning Ideas Into ActionsClick this link to deep-dive into the 341 companies within our  US Penny Stocks screener.Interested In Other Possibilities? The end of cancer? These 29 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.  This article by Simply Wall St is general in nature. We provide commentary based on historical data \n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your \n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data. \n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. \n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Elite Pharmaceuticals might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2610589586","isCrawlerRequest":true}